Mengmeng Han

Beijing Longfu Hospital, China

Title: Fifteen-year mortality and prognostic factors in patients with dilated cardiomyopathy: persistent standardized application of drug therapy and strengthened management may bring about encouraging change in an aging society

Abstract

The study aimed to investigate the all-cause mortality up to 15 years (mean 7.9 ± 5.7 years) in such patients, and the independent prognostic factors influencing their long-term mortality. One hundred and sixty-six consecutive patients with DCM were prospectively enrolled from 2002 to 2003. The mean age of patients was 59.5 ± 10.4 years, and approximately 57% were male. They were followed up by telephone or outpatient visits at least every three months until 2019 or all-cause death occurred. Predictors of mortality were identified using multivariate logistic regression analysis. This study was the first to demonstrate a 15-year survival rate of 34% in DCM patients. The DCM patients’ first five-year all-cause mortality decreased significantly after continuous standardized treatment and intensive management. The mortality then plateaued in the following 10 years. Age ? 70 years, LVEF? 35% and SBP > 120 mmHg were independent predictors of 15-year all-cause mortality.

Biography

Mengmeng HAN completed master’s degree from Capital Medical University, Beijing, China. She is the attending physician of Beijing Longfu Hospital, China. He has publicated 4 articles that have been cited over 10 times.

WORLD CONGRESS ON HEART AND CARDIOVASCULAR DISEASES

HYBRID EVENT | MAY 18-19, 2023 | DUBAI, UAE

Mengmeng Han

Title: Fifteen-year mortality and prognostic factors in patients with dilated cardiomyopathy: persistent standardized application of drug therapy and strengthened management may bring about encouraging change in an aging society

Abstract

Biography

Organization Location

Mail us at

Our Social Presence

Call us at